Copley Equity-backed FMG Leading snaps up Broadbranch Advisors
- FMG Leading helps PE-backed healthcare companies design and test value creation and growth strategies.
- Copley Equity Partners invested in FMG Leading in 2022.
- Broadbranch Advisors provides companies with data and research on their markets and competitors to support strategic decision-making.
FMG Leading, a healthcare investment-focused advisory firm backed by Copley Equity Partners, announced the add-on of market intelligence and strategic advisory firm BroadBranch Advisors. The deal closed at the end of July, and no financial details were disclosed.
Based in San Diego, FMG Leading helps private equity-backed healthcare organizations design and vet value creation and growth strategies. Copley Equity Partners backed it in 2022.
Broadbranch Advisors operates out of Washington, DC, and provides companies with data and research on their markets and competition as support for strategic decision-making.
“In today’s high-pressure landscape, translating forward-looking intelligence into action faster and more effectively is critical for our clients, especially in the investor-backed healthcare space,” said Matt Brubaker, CEO and Chairman of FMG Leading, in a statement. “By adding the market intelligence capabilities of BroadBranch Advisors, we’re further aligning our offerings to address this need, helping clients deliver on their performance, growth and missional goals.”
